Dana Goldman, PhD
Scientific Advisor, PHE
Leonard D. Schaeffer Director’s Chair and Distinguished Professor of Public Policy, Pharmacy, and Economics, University of Southern California
Dr. Goldman is the author of over 200 articles and book chapters. He is a health policy advisor to the Congressional Budget Office, the Fred Hutchinson Cancer Institute, and several healthcare companies. He also serves on the editorial boards of Health Affairs and the American Journal of Managed Care, and is founding editor of the Forum for Health Economics & Policy. His work has been featured in the New York Times, the Wall Street Journal, Washington Post, Business Week, The Economist, NBC Nightly News, CNN, and other media. Dr. Goldman is an elected member of the National Academy of Medicine, one of the highest health policy honors. He is the recipient of several prominent awards, including the Garfield Economic Impact Award, recognizing outstanding research on medicine and the economy; and the MetLife Foundation’s Silver Scholar Award, honoring aging research.
PhD, Economics, Stanford University
BA, Economics, Cornell University
ASSOCIATED CASE STUDIES
- Baicker K, et al. Patient cost-sharing and healthcare spending growth. J Econ Perspect. 2011.
- Blumenthal DM, et al. Outcomes-based pricing as a tool to ensure access to novel but expensive biopharmaceuticals. Ann Intern Med. 2017.
- Dzau VJ. Aligning incentives to fulfill the promise of personalised medicine. Lancet. 2015.
- Goldman DP, et al. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007.
- Sachs RE, et al. Encouraging new uses for old drugs. JAMA. 2017.